Results 91 to 100 of about 22,093 (176)

Pneumococcie invasive de sérotype vaccinal 9V chez des adultes vaccinés antérieurement. [PDF]

CMAJ
Deviaene M, Golden AR, Wuerz T, Sharma A.   +3 more
europepmc   +1 more source

Vaccines and vaccination strategies

Expert Review of Vaccines, 2004
openaire   +2 more sources

[Post-exposure prophylaxis against Ebola virus: arguments for expanding the role of monoclonal antibodies in a context of limited access]. [PDF]

Med Trop Sante Int
Potet J, Adjaho I, Dierberg K, Sprecher A, Coulborn RM.   +4 more
europepmc   +1 more source

Surveillance de la rougeole en Côte d’Ivoire de 2010 à 2022: Épidémiologie – Facteurs associés – Recommandations. [PDF]

J Public Health Afr
Ekra KD, Guehi CHH, Okoubo G, Ahoussou ÉM.   +3 more
europepmc   +1 more source

Characteristics of COVID-19 vaccine hesitancy in university students: Methodological insights from a syndemic perspective. [PDF]

Hum Vaccin Immunother
Yu T, Yuan J, Wang L, Li M.
europepmc   +1 more source

Les registres de vaccination, un outil essentiel pour éliminer la rougeole au Canada. [PDF]

CMAJ
Brown EM, Chambers C, Wilson SE.
europepmc   +1 more source

Ab Osterhaus: My life in virology. [PDF]

Hum Vaccin Immunother
Osterhaus A.
europepmc   +1 more source

The impact of nonpharmaceutical interventions (NPIs) on rabies post-exposure prophylaxis: A comparative study in Wuhan, 2022 vs. 2023. [PDF]

Hum Vaccin Immunother
Du YT, Hu X, Zhu ZG, Fan HQ, Liu MQ.
europepmc   +1 more source

Nanomaterial-based vaccines: An advanced approach against rotavirus: A review article. [PDF]

Hum Vaccin Immunother
Soroush Fard A, Kalantar K, Teimoori A, Barati M, Arezumand R, Fani M.   +5 more
europepmc   +1 more source

Age-group differential trends in the incidence of herpes zoster during 2010-2024 using Korean national healthcare claim data. [PDF]

Hum Vaccin Immunother
Cho H, Choe YJ, Shin JY, Choi B.
europepmc   +1 more source